metformin has been researched along with Allergic Encephalomyelitis in 3 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paintlia, AS | 1 |
| Paintlia, MK | 2 |
| Mohan, S | 1 |
| Singh, AK | 1 |
| Singh, I | 2 |
| Sun, Y | 1 |
| Tian, T | 1 |
| Gao, J | 1 |
| Liu, X | 1 |
| Hou, H | 1 |
| Cao, R | 1 |
| Li, B | 1 |
| Quan, M | 1 |
| Guo, L | 1 |
| Nath, N | 1 |
| Khan, M | 1 |
| Hoda, MN | 1 |
| Giri, S | 1 |
3 other studies available for metformin and Allergic Encephalomyelitis
| Article | Year |
|---|---|
AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model.
Topics: AMP-Activated Protein Kinases; Animals; Central Nervous System; Central Nervous System Agents; Cytok | 2013 |
Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice.
Topics: Analysis of Variance; Animals; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Exp | 2016 |
Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis.
Topics: AMP-Activated Protein Kinases; Animals; Cells, Cultured; Central Nervous System; Chronic Disease; Cy | 2009 |